Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Relay Therapeutics Inc (RLAY)

Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Healthcare - stethoscope-with-injection-protective-mask-lying-over-medical-chart-SBI-300904603
5 Biotech Stocks With 26% Upside Potential or More Barchart - Thu Mar 7, 1:13PM CST

As biotech stocks swing back into favor on Wall Street, here's a look at five picks that could deliver significant gains, according to analysts.

$SPX : 5,539.53 (+0.63%)
NVO : 132.59 (+0.80%)
BIIB : 224.34 (-0.91%)
KNSA : 20.92 (-1.46%)
SWTX : 36.43 (-3.42%)
RLAY : 8.59 (-0.12%)
ADPT : 4.00 (-0.99%)
GS : 487.24 (+0.48%)
Author
Unlocking AI investment opportunities in healthcare MarketBeat - Thu Nov 16, 2023

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

INTC : 33.10 (+0.36%)
NVDA : 122.73 (+4.07%)
RXRX : 7.56 (-0.66%)
RLAY : 8.59 (-0.12%)
EXAI : 4.95 (-3.70%)
RENB : 1.3150 (-2.59%)
BTAI : 1.1550 (-1.28%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028 FinancialNewsMedia - Fri May 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:PFE),(NASDAQ:OCEA),(NYSE:NVS),(NASDAQ:RLAY) EQNX::TICKER_END

ONCY : 1.0250 (-0.49%)
ONC.TO : 1.41 (unch)
PFE : 29.63 (-1.13%)
OCEA : 1.0950 (-0.45%)
NVS : 107.89 (+1.66%)
RLAY : 8.59 (-0.12%)
The Global Metastatic Breast Cancer Treatment Market Expected To Reach $31 Billion By 2028 PR Newswire - Fri May 26, 2023

/PRNewswire/ -- Metastatic breast cancer is the advanced stage of breast cancer, including cases wherein cancer has spread to the other parts of the body from...

ONC.TO : 1.41 (unch)
ONCY : 1.0250 (-0.49%)
PFE : 29.63 (-1.13%)
OCEA : 1.0950 (-0.45%)
NVS : 107.89 (+1.66%)
RLAY : 8.59 (-0.12%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer FinancialNewsMedia - Fri Mar 24, 2023

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – March 24, 2023 – USA News Group  –  Treatments for various forms of breast cancer continue to evolve, with several new...

BCTX : 0.6999 (-11.41%)
ONCY : 1.0250 (-0.49%)
ONC.TO : 1.41 (unch)
CTMX : 1.3900 (+0.72%)
BCT.TO : 0.94 (-17.54%)
RLAY : 8.59 (-0.12%)
HOLX : 77.93 (-0.23%)
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer PR Newswire - Fri Mar 24, 2023

/PRNewswire/ -- USA News Group - Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in...

BCTXW : 0.1700 (+0.83%)
ONC.TO : 1.41 (unch)
BCT.TO : 0.94 (-17.54%)
ONCY : 1.0250 (-0.49%)
CTMX : 1.3900 (+0.72%)
BCTX : 0.6999 (-11.41%)
RLAY : 8.59 (-0.12%)
HOLX : 77.93 (-0.23%)
Breast Cancer Treatment Options Evolved Over the Last 12 Months, Bringing More Hope for 2023 BayStreet.ca - Tue Mar 14, 2023

USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in nature and giving hope to families dealing with a fateful...

BCTX : 0.6999 (-11.41%)
ONCY : 1.0250 (-0.49%)
ONC.TO : 1.41 (unch)
CTMX : 1.3900 (+0.72%)
BCT.TO : 0.94 (-17.54%)
RLAY : 8.59 (-0.12%)
HOLX : 77.93 (-0.23%)
Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008 Business Wire - Mon Sep 12, 2022

Today Foundation Medicine, Inc. , a pioneer in molecular profiling for cancer, and Relay Therapeutics (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process...

RLAY : 8.59 (-0.12%)
Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights Globe Newswire - Thu Jul 28, 2022

CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...

RLAY : 8.59 (-0.12%)
Relay Therapeutics Discloses Anticipated Registrational Path for RLY-4008 in Cholangiocarcinoma and Growing Breast Cancer Franchise at Virtual Analyst and Investor Event Globe Newswire - Mon Jun 27, 2022

End-of-phase 1 meeting with the U.S. Food and Drug Administration (FDA) resulted in alignment on the design of a single arm trial for pan-FGFR (FGFRi)...

RLAY : 8.59 (-0.12%)

Barchart Exclusives

Up 121% Since May, What's Behind the Surge in this Penny Stock? Barchart - 55 minutes ago
BuzzFeed is a beaten-down tech stock that has gained traction in recent months as several high-profile investors have taken a stake in the media company. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot